TY  - GEN
AU  - Wang,Hui Qin
AU  - Halilovic,Ensar
AU  - Li,Xiaoyan
AU  - Liang,Jinsheng
AU  - Cao,Yichen
AU  - Rakiec,Daniel P
AU  - Ruddy,David A
AU  - Jeay,Sebastien
AU  - Wuerthner,Jens U
AU  - Timple,Noelito
AU  - Kasibhatla,Shailaja
AU  - Li,Nanxin
AU  - Williams,Juliet A
AU  - Sellers,William R
AU  - Huang,Alan
AU  - Li,Fang
TI  - Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human 
SN  - 2050-084X
PY  - 2018///0212
KW  - Anaplastic Lymphoma Kinase
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Cell Line, Tumor
KW  - Disease Models, Animal
KW  - Drug Resistance, Neoplasm
KW  - Heterografts
KW  - Humans
KW  - Mice, Nude
KW  - Neoplasm Transplantation
KW  - Neuroblastoma
KW  - drug therapy
KW  - Proto-Oncogene Proteins c-mdm2
KW  - antagonists & inhibitors
KW  - Pyrimidines
KW  - Receptor Protein-Tyrosine Kinases
KW  - Sulfones
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.7554/eLife.17137
ER  -